Shares of Stem, Inc. (NYSE:STEM – Get Free Report) have earned a consensus rating of “Reduce” from the six research firms that are currently covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell rating and four have issued a hold rating on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $17.60.
Several equities research analysts have weighed in on STEM shares. Barclays reiterated a “reduce” rating and issued a $18.00 price objective (up from $13.00) on shares of Stem in a report on Friday, October 31st. UBS Group boosted their price objective on shares of Stem from $16.00 to $18.00 and gave the stock a “neutral” rating in a research note on Friday, October 31st. Roth Mkm set a $23.00 target price on Stem and gave the stock a “neutral” rating in a research note on Thursday, October 30th. Finally, Weiss Ratings downgraded shares of Stem from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, February 11th.
Check Out Our Latest Research Report on Stem
Hedge Funds Weigh In On Stem
Stem Stock Down 2.5%
NYSE:STEM opened at $11.35 on Friday. The company has a fifty day moving average of $15.47 and a 200 day moving average of $17.22. The firm has a market capitalization of $95.22 million, a P/E ratio of -0.83 and a beta of 1.29. Stem has a 52 week low of $5.81 and a 52 week high of $32.23.
Key Stem News
Here are the key news stories impacting Stem this week:
- Neutral Sentiment: Near-term catalyst: analyst/press note says Stem (STEM) is expected to announce earnings on Wednesday — this is the primary event that could move the share price depending on results and guidance. Stem (STEM) Expected to Announce Earnings on Wednesday
- Neutral Sentiment: Local/community STEM education events (SC4 STEM Fest) — unrelated to Stem, Inc.’s energy-storage and software business; minimal/no impact on the stock. SC4 STEM Fest returns with 150+ hands-on activities
- Neutral Sentiment: Articles about biological “stem cells” and research (particle analysis supporting stem cell research; stem cell patch for fetal spina bifida; in‑utero stem cell therapy; stem cells treating frailty) — scientifically notable but unrelated to Stem, Inc.’s commercial profile; unlikely to affect the stock. How particle shape and size analysis supports stem cell research
- Neutral Sentiment: More community/education items (GNOSEF 70 years celebration; Fort Wayne school STEM focus boosting enrollment; STEM day at Phoenix Raceway) — positive for STEM education generally but not tied to Stem, Inc.’s financials or contracts. GNOSEF Celebrates 70 Years of STEM
- Negative Sentiment: Near-term risk: absence of fresh company-level news combined with a small market cap, negative earnings (negative P/E), and share price below recent moving averages can increase sensitivity to earnings misses or weak guidance — this likely contributed to today’s weaker trading.
Stem Company Profile
Stem, Inc is a technology company specializing in AI-driven energy storage and optimization solutions for commercial, industrial and utility customers. The company delivers integrated hardware and software systems that enable clients to manage energy consumption, reduce peak demand charges and provide ancillary services to the power grid. By combining battery storage hardware with advanced machine-learning algorithms, Stem helps organizations align energy usage with cost-saving opportunities while supporting grid reliability and renewable integration.
At the core of Stem’s offering is its Athena software platform, which uses real-time data and predictive analytics to forecast energy needs and automatically dispatch stored energy when it is most valuable.
Featured Articles
- Five stocks we like better than Stem
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.
